Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Trading Statement

24 Jan 2017 07:00

RNS Number : 8975U
Empresaria Group PLC
24 January 2017
 

24 January 2017

 

Empresaria Group plc

("Empresaria" or the "Group")

Trading Update and Notice of Results

Record profit, ahead of market expectations

 

Empresaria (AIM: EMR), the international specialist staffing group, today announces a trading update for the financial year ended 31 December 2016, ahead of announcing its final results on Wednesday 1 March 2017.

 

The Board is pleased to advise that full year profitability will be slightly ahead of market expectations. Adjusted profit before tax growth is expected to be approximately 23% year on year, representing a record profit level for the Group. Net fee income is approximately 20% ahead of the prior year and diluted adjusted earnings per share is expected to be up 12% on the prior year.

There were strong performances across the Group, with Headway in Germany, Skillhouse in Japan and Monroe in South East Asia all delivering solid growth year on year. In addition, the Group's businesses in Finland, Australia, China, India, Chile and the Technical & Industrial brands in the UK performed well. As announced at the half year, following a short period of uncertainty in the UK prior to the EU referendum, the UK region has seen stable activity levels return. Overall in the UK, this has led to profitability being down year on year, however the Group has reduced costs and is encouraged by the increased business activity as it moves into 2017. In the Middle East, the weak economic conditions persisted in the second half and expected improvements did not materialise. The business has been restructured accordingly and the Group expects an improved result in 2017 from this region.

The Group's USA investment, Pharmaceutical Strategies, is integrating well, having won a number of new clients and improved penetration across key clients. The decision during the year to invest in their management team and their largest client having reduced its overall spend on staffing requirements has resulted in a short-term impact on profitability. Despite this, the business continues to see good growth opportunities going forward.

As part of its 'Invest & Develop' strategy, the Group invested in two international brands in the period, strengthening the Group's presence in key global growth sectors. In July, the Group invested in Rishworth Aviation, the second largest recruitment company in the Aviation sector, operating across the UK, Continental Europe and Asia Pacific regions. The second investment, in October, was ConSol Partners, a specialist IT recruiter with a focus on the niche sectors of communications & mobile, cloud technologies and the digital supply chain, operating across the UK, Continental Europe and USA. Both businesses are performing well and demonstrating positive growth potential for the coming years.

Joost Kreulen, Chief Executive of Empresaria, said:

"Empresaria has demonstrated the benefit of its diversified business model, producing strong results with adjusted profit before tax up 23% on the prior year. We continue to deliver on our strategy: strengthening a multi-branded group, with a focus on developing leading brands that are diversified and balanced by geography and sector.

Alongside the strong growth in a number of regions, we are particularly pleased with the performance of the two international investments made during the year: Rishworth Aviation and ConSol Partners, with both performing well. These, alongside the successful integration of Pharmaceutical Strategies, are all important illustrations of the success of the Group's 'Invest & Develop' strategy and we look forward to the growth opportunity that these businesses have as part of the wider Group.

 

Overall, we are pleased with the record profit the Group has delivered, once again showing the strength of the diversified business model and the strategy the Group is delivering on. As such, we continue to see exciting growth opportunities for the Group in 2017."

 

Enquiries:

 

Empresaria Group plc

Joost Kreulen, Chief Executive Officer

Spencer Wreford, Group Finance Director

 

via Redleaf

Arden Partners (Nominated Adviser and Broker)John Llewellyn-Lloyd / Steve Douglas / Ciaran Walsh

020 7614 5900

Redleaf Communications (Financial PR)Rebecca Sanders Hewett / Sarah Fabietti-Dallison /

Sam Modlin

020 7382 4730

empresaria@redleafpr.com

 

Notes for editors:

 

· Empresaria Group plc is an international specialist staffing group with 21 brands operating in 19 countries across the globe including the UK, Germany, Japan, India, UAE, Indonesia, Chile, Australia, Thailand, Singapore, Finland, USA, New Zealand, China, Malaysia and the Philippines.

· Empresaria offers temporary/contract and permanent staffing solutions as well as Offshore Recruitment Services in seven key sectors: Technical & Industrial, Aviation Services, IT & Design, Professional Services, Healthcare, Executive search and Retail.

· Empresaria applies a multi brand, management equity philosophy and business model, with Empresaria group company management teams holding significant equity in their own business.

· Empresaria is listed on AIM under ticker EMR. For more information: empresaria.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDMGZMRFDGNZM

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.